A pre-post trial to examine biological mechanisms of the effects of time-restricted eating on symptoms and quality of life in bipolar disorder.

Autor: Johnson, Sheri L.¹ (AUTHOR), Murray, Greg² (AUTHOR), Manoogian, Emily N. C.³ (AUTHOR), Mason, Liam⁴ (AUTHOR), Allen, J. D.¹ (AUTHOR), Berk, Michael⁵ (AUTHOR), Panda, Satchidananda³ (AUTHOR), Rajgopal, Nandini A.¹ (AUTHOR), Gibson, Jake C.¹ (AUTHOR), Bower, Carter D.¹ (AUTHOR), Berle, Eline F.¹ (AUTHOR), Joyner, Keanan¹ (AUTHOR), Villanueva, Robert¹ (AUTHOR), Michalak, Erin E.⁶ (AUTHOR), Kriegsfeld, Lance J.^1,7 (AUTHOR) Kriegsfeld@berkeley.edu

Publikováno v: BMC Psychiatry. 10/23/2024, Vol. 24 Issue 1, p1-19. 19p.

Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline.

Autor: Miranda R Jr; From the, Department of Psychiatry and Human Behavior, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Brown University, Providence, Rhode Island, USA.; Department of Psychiatry, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Yale School of Medicine, New Haven, Connecticut, USA.; Division of Medications Development, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA., O'Malley SS; From the, Department of Psychiatry and Human Behavior, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Brown University, Providence, Rhode Island, USA.; Department of Psychiatry, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Yale School of Medicine, New Haven, Connecticut, USA.; Division of Medications Development, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA., Treloar Padovano H; From the, Department of Psychiatry and Human Behavior, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Brown University, Providence, Rhode Island, USA.; Department of Psychiatry, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Yale School of Medicine, New Haven, Connecticut, USA.; Division of Medications Development, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA., Wu R; From the, Department of Psychiatry and Human Behavior, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Brown University, Providence, Rhode Island, USA.; Department of Psychiatry, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Yale School of Medicine, New Haven, Connecticut, USA.; Division of Medications Development, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA., Falk DE; From the, Department of Psychiatry and Human Behavior, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Brown University, Providence, Rhode Island, USA.; Department of Psychiatry, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Yale School of Medicine, New Haven, Connecticut, USA.; Division of Medications Development, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA., Ryan ML; From the, Department of Psychiatry and Human Behavior, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Brown University, Providence, Rhode Island, USA.; Department of Psychiatry, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Yale School of Medicine, New Haven, Connecticut, USA.; Division of Medications Development, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA., Fertig JB; From the, Department of Psychiatry and Human Behavior, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Brown University, Providence, Rhode Island, USA.; Department of Psychiatry, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Yale School of Medicine, New Haven, Connecticut, USA.; Division of Medications Development, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA., Chun TH; From the, Department of Psychiatry and Human Behavior, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Brown University, Providence, Rhode Island, USA.; Department of Psychiatry, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Yale School of Medicine, New Haven, Connecticut, USA.; Division of Medications Development, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA., Muvvala SB; From the, Department of Psychiatry and Human Behavior, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Brown University, Providence, Rhode Island, USA.; Department of Psychiatry, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Yale School of Medicine, New Haven, Connecticut, USA.; Division of Medications Development, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA., Litten RZ; From the, Department of Psychiatry and Human Behavior, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Brown University, Providence, Rhode Island, USA.; Department of Psychiatry, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Yale School of Medicine, New Haven, Connecticut, USA.; Division of Medications Development, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA.

Publikováno v: Alcoholism, clinical and experimental research [Alcohol Clin Exp Res] 2020 Jul; Vol. 44 (7), pp. 1431-1443. Date of Electronic Publication: 2020 May 25.

Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and Safety.

Autor: Falk DE; National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland., Ryan ML; National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland., Fertig JB; National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland., Devine EG; Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts., Cruz R; Section of General Internal Medicine, Department of Medicine, School of Medicine and Boston Medical Center, Section of General Internal Medicine, Boston University, Boston, Massachusetts., Brown ES; Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, Texas., Burns H; Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, Texas., Salloum IM; Division of Alcohol and Substance Abuse, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, Florida., Newport DJ; Division of Alcohol and Substance Abuse, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, Florida., Mendelson J; Friends Research Institute, San Francisco, California., Galloway G; Friends Research Institute, San Francisco, California., Kampman K; Department of Psychiatry, Perelman School of Medicine, Center for Studies of Addiction, University of Pennsylvania, Philadelphia, Pennsylvania., Brooks C; Department of Psychiatry, Perelman School of Medicine, Center for Studies of Addiction, University of Pennsylvania, Philadelphia, Pennsylvania., Green AI; Department of Psychiatry, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire., Brunette MF; Department of Psychiatry, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire., Rosenthal RN; Division of Addiction Psychiatry, Stony Brook University, Stony Brook, New York.; Mount Sinai St. Luke's Hospital, New York, New York., Dunn KE; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland., Strain EC; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland., Ray L; Department of Psychology and Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, California., Shoptaw S; Department of Family Medicine and of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California., Ait-Daoud Tiouririne N; Center for Leading Edge Addiction Research, University of Virginia, Charlottesville, Virginia., Gunderson EW; Department of Psychiatry and Neurobehavioral Sciences and Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia., Ransom J; Fast Track Drugs and Biologics, North Potomac, Maryland., Scott C; Fast Track Drugs and Biologics, North Potomac, Maryland., Leggio L; Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland., Caras S; Arbor Pharmaceuticals, LLC, Atlanta, Georgia., Mason BJ; Department of Neuroscience, The Scripps Research Institute, La Jolla, California., Litten RZ; National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.

Publikováno v: Alcoholism, clinical and experimental research [Alcohol Clin Exp Res] 2019 Jan; Vol. 43 (1), pp. 158-169. Date of Electronic Publication: 2018 Dec 09.

Associations between disordered eating behaviour and sexual behaviour amongst emerging adults attending a tertiary education institution in Coastal Kenya.

Autor: Chea, Stevenson K.^1,2 (AUTHOR) cheastevenson@gmail.com, Kazienga, Adama³ (AUTHOR), Oyugi, Eunice A.⁴ (AUTHOR), Menza, Isaac⁴ (AUTHOR), Nasambu, Carophine⁴ (AUTHOR), Ibrahim, Fauz⁵ (AUTHOR), Abdullahi, Osman A.⁶ (AUTHOR), Hassan, Amin S.^4,6 (AUTHOR), Abubakar, Amina^4,6,7,8 (AUTHOR), Michielsen, Kristien⁹ (AUTHOR), Abbeddou, Souheila² (AUTHOR)

Publikováno v: PLoS ONE. 6/11/2024, Vol. 19 Issue 6, p1-18. 18p.

A randomized controlled trial to compare the effects of time-restricted eating versus Mediterranean diet on symptoms and quality of life in bipolar disorder.

Autor: Johnson, Sheri L.¹ (AUTHOR) sljohnson@berkeley.edu, Murray, Greg² (AUTHOR), Kriegsfeld, Lance J.¹ (AUTHOR), Manoogian, Emily N.C.³ (AUTHOR), Mason, Liam⁴ (AUTHOR), Allen, J. D.¹ (AUTHOR), Berk, Michael⁵ (AUTHOR), Panda, Satchidanda³ (AUTHOR), Rajgopal, Nandini A.¹ (AUTHOR), Gibson, Jake C.¹ (AUTHOR), Joyner, Keanan J.¹ (AUTHOR), Villanueva, Robert¹ (AUTHOR), Michalak, Erin E.⁶ (AUTHOR)

Publikováno v: BMC Psychiatry. 5/18/2024, Vol. 24 Issue 1, p1-21. 21p.